KINGWOOD, Texas – August 9, 2026 (STL.News) Maryam Qayum – Texas physician Maryam Qayum has been sentenced to 12.5 years in federal prison after admitting her role in a cash-only pill mill that federal authorities said issued prescriptions for more than 3 million opioid pills between 2022 and 2025.
The case is disturbing not simply because of the staggering volume of controlled substances involved, but because of what prosecutors say occurred inside a business presented to the public as a medical clinic.
According to the U.S. Department of Justice, Maryam Qayum, 68, of Montgomery County, owned and operated Recare Health Clinic in Kingwood and served as its sole prescriber. Federal authorities said the clinic sold prescriptions for powerful opioids to street-level drug dealers, issued prescriptions without a legitimate medical purpose and frequently did so without Qayum ever interacting with the purported patient.
Qayum pleaded guilty in March 2026 to conspiracy to unlawfully distribute controlled substances. Her sentence represents accountability for serious criminal conduct, but the broader questions raised by the case should not end with her imprisonment.
When a physician turns prescribing authority into a source of illegal drug distribution, the damage spreads across society. Addiction can be fueled. Criminal markets receive additional inventory. Healthcare and public-safety systems absorb additional costs. And every such prosecution risks damaging the public trust upon which legitimate medicine depends.
Maryam Qayum – How Recare Health Clinic Operated
The Justice Department described Recare as a cash-only pill mill that sold controlled-substance prescriptions to people identified at the clinic as “providers.” According to prosecutors, those providers were street-level drug dealers who obtained prescriptions for high-strength oxycodone and hydrocodone.
The federal indictment provides an even more troubling picture.
Prosecutors alleged that individuals were brought to the clinic as purported patients so prescriptions could be obtained and later filled at Houston-area pharmacies. The indictment identified defendant Melvin Sampson as a crew leader who coordinated the movement of purported patients through clinics and pharmacies.
According to the indictment, Qayum often did not see, examine, or interact with people for whom she prescribed oxycodone, hydrocodone, or carisoprodol. Instead, prosecutors said nonphysician personnel sometimes conducted cursory encounters before the controlled substances were prescribed. The indictment alleged those prescriptions were issued without a legitimate medical purpose and outside the usual course of professional practice.
That distinction is critical. Physicians unquestionably have legitimate reasons to prescribe opioids. These medications remain important tools for treating severe pain when appropriately prescribed and monitored. The criminal issue in this case was not simply that Qayum prescribed opioids. It was that she admitted participating in a conspiracy to distribute controlled substances unlawfully.
Maryam Qayum – Prescription Prices Followed Street Value
The Justice Department said Recare’s pricing practices also differed dramatically from those of a conventional medical clinic.
According to court documents, the clinic charged as much as $500 for a prescription for 30-milligram oxycodone, while hydrocodone prescriptions frequently cost about $300. Prosecutors said staff members also accepted “tips” from drug dealers to expedite patients and prescriptions.
Federal investigators seized a handwritten note from the clinic listing cash prices for controlled-substance prescriptions.
Those allegations matter because they portray a system in which the monetary value of the prescription itself — rather than the complexity of medical treatment — influenced what customers paid.
The indictment also alleged that security guard Lester Stokes helped move purported patients, runners and crew leaders through the process and received cash tips in exchange for facilitating access.
That is not merely questionable medical judgment. Prosecutors described an organized distribution structure involving a doctor, clinic personnel, street-level dealers and a pharmacy.
Maryam Qayum – Four Other Defendants Were Sentenced
Maryam Qayum was not prosecuted in isolation.
Four additional defendants were sentenced for their involvement in the case, underscoring the network federal authorities said existed around Recare.
Melvin Sampson, 56, of Houston, received the longest sentence among the co-defendants: 210 months in federal prison. The Justice Department said Sampson brought patients to Recare, filled prescriptions at Surge Rx and elsewhere, and resold the drugs on the black market. He pleaded guilty in March to conspiracy to unlawfully distribute controlled substances.
Tomi-Ko Bowers, APRN, 71, of Cleveland, Texas, was sentenced to 96 months in prison. She worked as a nurse practitioner at Recare and also pleaded guilty to the conspiracy charge.
Lester Stokes, 38, of Houston, who worked as Recare’s security guard, received a 63-month sentence after pleading guilty to conspiracy to distribute controlled substances unlawfully.
Jared Williams, RPh, 49, of Pearland, received 42 months in prison. Williams owned Surge Rx and served as its pharmacist-in-charge. He pleaded guilty to unlawfully distributing a controlled substance, and the Justice Department said his pharmacy filled illegitimate prescriptions issued by Qayum.
The Drug Enforcement Administration and Conroe Police Department investigated the case.
Pill Mills Cause Damage Far Beyond Their Doors
The criminal justice system can measure prison sentences. It can count pills, prescriptions, defendants and convictions.
The social consequences of illegal opioid distribution are considerably harder to quantify.
Opioids remain an important part of America’s drug-overdose crisis. The latest National Center for Health Statistics estimates available in 2026 showed approximately 44,564 opioid-involved overdose deaths in 2025. That represented a substantial decline from the estimated 55,296 opioid-involved deaths in 2024, but the number remains an enormous public-health burden.
It is important not to confuse the modern overdose crisis with the prescription-drug crisis of earlier years. Illicitly manufactured fentanyl became the dominant driver of opioid overdose deaths, and today’s illegal drug market is substantially different from the market that helped ignite the opioid epidemic decades ago. CDC data show the country has recently made meaningful progress in reducing overdose mortality.
But improvement does not make unlawful prescription diversion harmless.
When prescription opioids are intentionally introduced into an illegal market, they create another supply of addictive controlled substances outside legitimate medical supervision. That is precisely why federal law treats unlawful prescribing as drug distribution rather than merely a professional disciplinary matter.
Three million pills from one operation is not an inconsequential quantity.
Maryam Qayum – Addiction Carries Costs for Entire Communities
Drug addiction rarely affects only the person using the substance.
Families may face lost income, disrupted relationships, medical emergencies and the emotional consequences of substance-use disorders. Employers can face absenteeism and lost productivity. Hospitals and emergency departments treat overdoses and other complications. Treatment programs must provide continuing care. Police, prosecutors and courts spend resources addressing crimes associated with illegal drug markets.
Those costs are ultimately distributed throughout society.
Healthcare expenses are paid through a combination of private insurance premiums, employer-sponsored health plans, Medicare, Medicaid, taxpayers and patients themselves. It would be inaccurate to claim that Qayum’s operation alone caused anyone’s insurance premium to rise. Insurance pricing involves far too many variables to make that assertion responsibly.
The broader proposition, however, is straightforward: preventable addiction, overdoses and related medical treatment add expenses to an already costly healthcare system.
When criminal conduct creates medical problems that otherwise might not have occurred, somebody eventually pays for the consequences.
The Medical Profession Pays a Different Price
There is another cost that does not appear on an insurance statement.
Trust.
Physicians occupy a unique position in American life. Patients allow doctors access to their bodies, medical histories and highly personal information. They routinely make decisions involving surgery, powerful medications and even life-or-death treatment based on a physician’s recommendation.
That relationship cannot function effectively without trust.
A case in which prosecutors establish that a licensed physician sold prescriptions to drug dealers damages that trust in a way an ordinary drug-trafficking prosecution does not.
Maryam Qayum’s conduct should not be used to judge the overwhelming majority of physicians. Doctors who follow prescribing rules, carefully evaluate patients, and practice ethical medicine have nothing to do with this crime. In fact, they can become secondary victims of cases like this because they must practice in the atmosphere of skepticism created by colleagues who abuse their licenses.
Responsible pain-management physicians also face difficult consequences from past opioid abuses. They must balance legitimate patients’ need for pain relief against diversion and addiction risks while complying with increasingly sophisticated monitoring requirements.
Every pill-mill prosecution makes that job harder.
Regulation Exists, but Oversight Still Deserves Scrutiny
It would be inaccurate to say physicians or controlled substances are unregulated.
They are heavily regulated.
Texas operates a Prescription Monitoring Program overseen by the Texas State Board of Pharmacy. The system collects outpatient prescription information for Schedule II, III, IV and V controlled substances dispensed by pharmacies in Texas or to Texas residents. State officials describe the PMP as a tool intended to inform prescribing and address misuse, diversion and overdose.
Texas law also imposes mandatory PMP lookup requirements for certain controlled substances. Pharmacists are required to review a patient’s controlled-substance history before dispensing opioids and several other specified drug classes, subject to applicable statutory rules and exceptions.
Those safeguards make the Recare case more—not less—worthy of scrutiny.
The correct question is not why there was no regulation.
The question is how a criminal conspiracy that federal authorities say generated prescriptions for more than three million opioid pills was able to continue from 2022 until law enforcement shut the clinic down in 2025.
No regulatory system can prevent every crime. People deliberately engaged in criminal conspiracies design their conduct to avoid detection.
Still, three million pills provide ample reason for medical boards, pharmacy regulators, insurers, prescription-monitoring officials, and law enforcement agencies to examine whether available data can identify extreme prescribing patterns sooner.
If sophisticated prescription-monitoring systems can detect unusual activity, society should expect those warnings to be investigated aggressively.
Enforcement Must Match the Public Harm
The Maryam Qayum case is not an isolated example of federal authorities targeting pill-mill operations.
DEA and Justice Department investigations have repeatedly uncovered networks involving doctors, clinic owners, pharmacists, recruiters and drug dealers. In a major Houston-area enforcement action announced in 2019, for example, federal authorities charged 41 people in a network accused of diverting approximately 23 million oxycodone, hydrocodone and carisoprodol pills.
The Justice Department also says its Health Care Fraud Strike Force Program has charged more than 6,200 defendants since 2007 who collectively billed federal healthcare programs and private insurers more than $45 billion.
Those figures demonstrate two things simultaneously.
Enforcement exists and produces substantial criminal cases.
But the financial incentives behind healthcare fraud and controlled-substance diversion remain large enough that some individuals continue taking the risk.
That makes deterrence essential.
A physician considering selling prescriptions should understand that the consequences can include loss of a career, federal conviction, and more than a decade behind bars. Pharmacists and clinic employees who knowingly participate should understand that professional titles do not insulate them from prosecution.
Maryam Qayum’s Sentence Should Be a Warning
The most troubling element of this case is not simply that illegal drugs allegedly changed hands.
It is where the distribution began.
A medical clinic is supposed to be a place where illness is treated, and suffering is reduced. A prescription pad is supposed to represent a physician’s medical determination that a patient needs a particular medication.
When that authority is converted into a mechanism for supplying street-level dealers, the harm extends beyond controlled substances.
It corrupts one of society’s most important relationships.
Maryam Qayum pleaded guilty. Four other defendants also pleaded guilty and received federal prison sentences. The government therefore does not need to speculate about whether a criminal enterprise existed: convictions and guilty pleas now establish criminal responsibility for the participants who have been sentenced.
The remaining question belongs to society.
How quickly can similar operations be identified in the future?
The answer should involve stronger use of prescribing data, cooperation among pharmacies and regulators, professional accountability, effective law enforcement and a medical culture unwilling to tolerate behavior that places profits ahead of patients.
The United States has made measurable progress against overdose deaths. That progress should strengthen—not weaken—the resolve to eliminate sources of illegally diverted opioids.
Millions of pills should never have to leave a clinic before everyone realizes something is terribly wrong.
This news article can also be viewed on USPress.News
